EurekAlert! News by Subject: Medicine & Health - News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 8-Jun-2025 02:09 ET (8-Jun-2025 06:09 GMT/UTC)

AI agents for oncology: Dresden research team develops system to support clinical decisions

Technische Universität Dresden
Peer-Reviewed Publication

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in collaboration with partners from Germany, the UK and USA, have developed and validated an autonomous artificial intelligence (AI) agent capable of supporting clinical decision-making in oncology. The findings were published in the journal Nature Cancer. In the future, AI agents could assist healthcare professionals in navigating complex medical data and supporting informed, personalized treatment decisions for cancer patients.

Journal: Nature Cancer

Chinese Medical Journal article reviews classification, synthesis, and applications of ‘herbzymes’

Chinese Medical Journals Publishing House Co., Ltd.
Peer-Reviewed Publication

Nanomaterials with catalytic properties that are derived from Chinese herbs are called ‘herbzymes’. Herbzymes are nanomaterials from Chinese herbs that mimic natural enzymes like peroxidase (POD), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). For a deeper understanding of herbzymes, researchers from China present a comprehensive review of different types of herbzymes and their mode of synthesis, while detailing their biomedical applications, current challenges faced, and potential directions for their development.

Journal: Chinese Medical Journal

New AI reimagines infectious disease forecasting

Johns Hopkins University
Peer-Reviewed Publication

A new AI tool to predict the spread of infectious disease outperforms existing state-of-the-art forecasting methods.

The tool, created with federal support by researchers at Johns Hopkins and Duke universities, could revolutionize how public health officials predict, track and manage outbreaks of infectious diseases including flu and COVID-19.

Journal: Nature Computational Science
Funder: U.S. National Science Foundation, Centers for Disease Control and Prevention, Center for Forecasting and Outbreak Analytics, Merck KGaA, U.S. National Science Foundation, Army Research Office

Ultra-selective aptamers give viruses a taste of their own medicine

Ecole Polytechnique Fédérale de Lausanne
Peer-Reviewed Publication

Inspired by the way viruses attach to cells, EPFL scientists have developed a method for engineering ultra-selective aptamers. These synthetic molecules bind to specific targets like viral spike proteins, making them useful for biomedical diagnostics and treatments.

Journal: Nature Nanotechnology

Scientific community urges greater action against the silent rise of liver diseases

Barcelona Institute for Global Health (ISGlobal)
Peer-Reviewed Publication

During the first meeting of the Global Think-tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on 5–6 June, more than 100 international experts issued a stark warning: millions of people will continue to go unseen by healthcare systems unless early detection and person-centred care for liver disease are prioritised without delay.

Journal: The Lancet Regional Health - Europe
Funder: Novo Nordisk, Echosens

Statins may reduce risk of death by 39% for patients with life-threatening sepsis

Frontiers
Peer-Reviewed Publication

It has been suggested that statins could boost the chances of survival of patients with sepsis because of their multipronged effects on inflammation. Here, researchers from China used the MIMIC-IV database to perform a retrospective cohort study on two large, matched groups: critically ill patients with sepsis in the Beth Israel Deaconess Medical Center who received standard of care with or without statins. The 28-day all-cause mortality was 39% lower in relative terms [an absolute reduction from 23.4% to 14.3%] in the statin group, suggesting a protective effect. Previous randomized controlled trials that didn’t find any such benefit might have been too small or have had other weaknesses. The present results need to be confirmed in a large, well-designed randomized clinical trial.

Journal: Frontiers in Immunology

Paradigm shift: Chinese scientists transform "dispensable" spleen into universal regenerative hub

Nanjing University School of Life Sciences
Peer-Reviewed Publication

NANJING, China – In a revolutionary one-two punch, Chinese research teams have successfully engineered the human spleen into a living bioreactor capable of curing diabetes and growing functional organs – achievements published back-to-back in Science Translational Medicine and Diabetes this month. This convergence of discoveries positions the long-underestimated spleen as a game-changing platform for regenerative medicine.

Journal: Diabetes

2
3
4
5
6

	
		OSZAR »